Syntheses and Functional Studies of Self‐Adjuvanting Anti‐HER2 Cancer Vaccines-Reference-Cited by-同舟云学术

Syntheses and Functional Studies of Self‐Adjuvanting Anti‐HER2 Cancer Vaccines

Published:2019-10-30 Issue:23 Volume:14 Page:4268-4273
ISSN:1861-4728
Container-title:Chemistry – An Asian Journal
language:en
Short-container-title:Chem. Asian J.

Author:

Feng Qi¹,Manabe Yoshiyuki¹²,Kabayama Kazuya¹²,Aiga Taku¹,Miyamoto Asuka³,Ohshima Shino³,Kametani Yoshie³,Fukase Koichi¹²^ORCID

Affiliation:

1. Department of ChemistryGraduate School of ScienceOsaka University Machikaneyama 1-1 Toyonaka, Osaka 560-0043 Japan

2. Core for Medicine and Science Collaborative Research and EducationProject Research Center for Fundamental SciencesOsaka University Machikaneyama 1-1 Toyonaka Osaka 560-0043 Japan

3. School of MedicineTokai University Isehara Kanagawa 259-1193 Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Chemistry,Biochemistry,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/asia.201901002

Reference57 articles.

1. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

2. Immune Effects of Trastuzumab

3. Herceptin: mechanisms of action and resistance

4. Anti-HER2 vaccines: new prospects for breast cancer therapy

5. Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2;Chemical Communications;2024

2. Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate;Journal of the American Chemical Society;2023-06-21

3. Chemical Biology Study for Elucidating and Regulating Emergent Glycan Functions;Journal of Synthetic Organic Chemistry, Japan;2023-02-01

4. Innovative Vaccine Strategy: Self-Adjuvanting Conjugate Vaccines;Glycolipids;2023

5. Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope;RSC Advances;2022